| Date | Event | Description |
|---|---|---|
| 10 November 2014 | Amended | Correction: in the updated review published in issue 2, 2014, there was a change to the conclusion for the primary outcome live birth. There was evidence of an increased number of live births with transfer media containing high concentrations of hyaluronic acid. |
| 13 November 2013 | New search has been performed | Meta‐analyses on hyaluronic acid have been grouped together. Instead of division into three different comparison groups, now only one group with a subgroup analysis of HA versus low HA and HA versus no HA for the live birth rate and the clinical pregnancy rate. Furthermore, ongoing pregnancy rate has been removed as a secondary outcome measure, and subgroup analyses have been removed from the secondary outcome measures of multiple pregnancy rate and adverse events rate |
| 13 November 2013 | New citation required but conclusions have not changed | Two studies added; no change made to conclusions |
| 12 May 2010 | Amended | Post‐protocol change: originally implantation rate was not planned for analysis but was to be presented as an additional table. However, we decided to present this outcome measure without pooling. |
| 8 July 2009 | Amended | Changed title and authoring team. Changes to protocol: inclusion of all types of adherence compounds, different outcome measures, multiple comparison groups, additional subgroup analyses. |